AGP Executive Report
Last update: 8 hours agoRobotics and Industrial Tech: China’s block on SoftBank’s planned $5.4 billion purchase of ABB’s robotics division leaves the deal in doubt and underscores Beijing’s tighter control of strategic technology. Life Sciences: Lonza agreed to buy five US manufacturing sites from Merck, expanding its contract manufacturing footprint. A new industry index, however, says Swiss pharma is lagging in technology and clinical trials. Manufacturing: Autoneum plans to acquire French automotive supplier Trèves, while Rieter announced a leadership change. Business Results: Barry Callebaut reported a 15.2% sales decline for FY2025/26 despite quarterly volume growth; Swiss Re increased profit in the first nine months.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.